<?xml version="1.0" encoding="UTF-8"?><rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>Research and Treatments Archives - Walking Strong</title>
	<atom:link href="https://walkingstrong.org/category/research-and-treatments/feed/" rel="self" type="application/rss+xml" />
	<link>https://walkingstrong.org/category/research-and-treatments/</link>
	<description>Together, We Can Cure Duchenne Muscular Dystrophy</description>
	<lastBuildDate>Thu, 22 May 2025 13:05:56 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>
	hourly	</sy:updatePeriod>
	<sy:updateFrequency>
	1	</sy:updateFrequency>
	

<image>
	<url>https://walkingstrong.org/wp-content/uploads/2018/04/favicon-150x150.png</url>
	<title>Research and Treatments Archives - Walking Strong</title>
	<link>https://walkingstrong.org/category/research-and-treatments/</link>
	<width>32</width>
	<height>32</height>
</image> 
	<item>
		<title>Targeted Therapies for DMD</title>
		<link>https://walkingstrong.org/targeted-therapies-for-dmd/</link>
					<comments>https://walkingstrong.org/targeted-therapies-for-dmd/#respond</comments>
		
		<dc:creator><![CDATA[Webmaster]]></dc:creator>
		<pubDate>Thu, 01 May 2025 19:36:55 +0000</pubDate>
				<category><![CDATA[Research and Treatments]]></category>
		<category><![CDATA[Duchenne muscular dystrophy]]></category>
		<guid isPermaLink="false">https://walkingstrong.cmsnc.website/?p=11437</guid>

					<description><![CDATA[<p>Targeted Therapies Aim at the Root of the Disease At the 2025 Muscular Dystrophy Association Clinical &#38; Scientific Conference in Dallas, Dr. Matthew Alexander, associate professor of pediatric neurology and genetics at the University of Alabama, Birmingham, led a compelling session on the future of muscular dystrophy treatment. The focus? Targeted therapies are designed to [&#8230;]</p>
<p>The post <a href="https://walkingstrong.org/targeted-therapies-for-dmd/">Targeted Therapies for DMD</a> appeared first on <a href="https://walkingstrong.org">Walking Strong</a>.</p>
]]></description>
		
					<wfw:commentRss>https://walkingstrong.org/targeted-therapies-for-dmd/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>FDA Finally Approves First Ever Treatment Drug &#8211; Finally!</title>
		<link>https://walkingstrong.org/fda-finally-approves-first-ever-treatment-drug-finally/</link>
					<comments>https://walkingstrong.org/fda-finally-approves-first-ever-treatment-drug-finally/#respond</comments>
		
		<dc:creator><![CDATA[Valerie]]></dc:creator>
		<pubDate>Tue, 27 Sep 2016 20:53:40 +0000</pubDate>
				<category><![CDATA[Research and Treatments]]></category>
		<guid isPermaLink="false">https://walkingstrong.org/?p=6547</guid>

					<description><![CDATA[<p>100 days after the FDA&#8217;s legally mandated decision date,the FDA announced accelerated approval for  Eteplirsen by Sarepta Therapeutics.  Eteplirsen is the first therapy drug approved for Duchenne which works to skip over the deleted exons.  The approval did come without bureaucratic &#8220;drama&#8221; and in-fighting.  There were definite opponents for approval, based on the nonsense of [&#8230;]</p>
<p>The post <a href="https://walkingstrong.org/fda-finally-approves-first-ever-treatment-drug-finally/">FDA Finally Approves First Ever Treatment Drug &#8211; Finally!</a> appeared first on <a href="https://walkingstrong.org">Walking Strong</a>.</p>
]]></description>
		
					<wfw:commentRss>https://walkingstrong.org/fda-finally-approves-first-ever-treatment-drug-finally/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>FDA &#8211; NOT FOR DUCHENNE</title>
		<link>https://walkingstrong.org/fda-not-for-duchenne/</link>
					<comments>https://walkingstrong.org/fda-not-for-duchenne/#respond</comments>
		
		<dc:creator><![CDATA[Nate Frazier]]></dc:creator>
		<pubDate>Tue, 26 Apr 2016 17:28:45 +0000</pubDate>
				<category><![CDATA[Research and Treatments]]></category>
		<guid isPermaLink="false">https://walkingstrong.org/?p=6424</guid>

					<description><![CDATA[<p>April 26, 2016 &#160; As I sit bleary-eyed  on the airplane flying home from what should have been a “successful” trip to DC, I am still stunned and disheartened from yesterday after a grueling TWELVE HOUR meeting with the FDA and it’s Advisory Committee, that went from an historic event into a catastrophe.   I want [&#8230;]</p>
<p>The post <a href="https://walkingstrong.org/fda-not-for-duchenne/">FDA &#8211; NOT FOR DUCHENNE</a> appeared first on <a href="https://walkingstrong.org">Walking Strong</a>.</p>
]]></description>
		
					<wfw:commentRss>https://walkingstrong.org/fda-not-for-duchenne/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>Clinical Trial &#8211; Day 1</title>
		<link>https://walkingstrong.org/clinical-trial-day-1/</link>
					<comments>https://walkingstrong.org/clinical-trial-day-1/#respond</comments>
		
		<dc:creator><![CDATA[Nate Frazier]]></dc:creator>
		<pubDate>Thu, 09 Jul 2015 18:21:04 +0000</pubDate>
				<category><![CDATA[Living with Duchenne]]></category>
		<category><![CDATA[Research and Treatments]]></category>
		<guid isPermaLink="false">https://walkingstrong.org/?p=6416</guid>

					<description><![CDATA[<p>I guess you can say &#8211; &#8220;we are lucky.&#8217;   After 5 days of putting Alexander through extensive testing (a 3 hour MRI, extensive bloodwork, ECG, Pulmonary, 2 days of physical therapy assessment,   fecal testing (ek!) and a physical exam), we received official word last night that he was accepted into a clinical trial for a [&#8230;]</p>
<p>The post <a href="https://walkingstrong.org/clinical-trial-day-1/">Clinical Trial &#8211; Day 1</a> appeared first on <a href="https://walkingstrong.org">Walking Strong</a>.</p>
]]></description>
		
					<wfw:commentRss>https://walkingstrong.org/clinical-trial-day-1/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
		<item>
		<title>CLINICAL TRIAL – No easy choices</title>
		<link>https://walkingstrong.org/clinical-trial-no-easy-choices/</link>
					<comments>https://walkingstrong.org/clinical-trial-no-easy-choices/#respond</comments>
		
		<dc:creator><![CDATA[Nate Frazier]]></dc:creator>
		<pubDate>Wed, 11 Feb 2015 16:11:07 +0000</pubDate>
				<category><![CDATA[Living with Duchenne]]></category>
		<category><![CDATA[Research and Treatments]]></category>
		<guid isPermaLink="false">https://walkingstrong.org/?p=6288</guid>

					<description><![CDATA[<p>On a Saturday morning at 9:00am I received a call from our Neurologist at UCLA. He called to tell me the news that there is a clinical trial at UCLA that Alexander could qualify for. After a 45 min conversation, I was left hopeful but at the same time anxious and a little sad. The [&#8230;]</p>
<p>The post <a href="https://walkingstrong.org/clinical-trial-no-easy-choices/">CLINICAL TRIAL – No easy choices</a> appeared first on <a href="https://walkingstrong.org">Walking Strong</a>.</p>
]]></description>
		
					<wfw:commentRss>https://walkingstrong.org/clinical-trial-no-easy-choices/feed/</wfw:commentRss>
			<slash:comments>0</slash:comments>
		
		
			</item>
	</channel>
</rss>
